Details of the Drug

General Information of Drug (ID: DM7DMR7)

Drug Name
ET190
Indication
Disease Entry ICD 11 Status REF
Haematological malignancy 2B33.Y Phase 1 [1]
Cross-matching ID
TTD ID
D02RHC

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)